GZMK Antikörper (AA 51-250)
Kurzübersicht für GZMK Antikörper (AA 51-250) (ABIN872626)
Target
Alle GZMK Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 51-250
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Granzyme K
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB 1:300-5000
ELISA 1:500-1000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- GZMK (Granzyme K (Granzyme 3, Tryptase II) (GZMK))
-
Andere Bezeichnung
- Granzyme K
-
Hintergrund
-
Synonyms: Fragmentin 3, Fragmentin-3, Fragmentin3, GRAK_HUMAN, Granzyme 3, Granzyme K, Granzyme K precursor, Granzyme-3, Granzyme3, GranzymeK, GZMK, NK TRYP 2, NK TRYP2, NK tryptase 2, NK-TRYP-2, NK-tryptase-2, NKTRYP2, Serine protease granzyme 3, TRYP 2, TRYP2, Tryptase II, TryptaseII.
Background: This gene product is a member of a group of related serine proteases from the cytoplasmic granules of cytotoxic lymphocytes. Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here lacks consensus sequences for N-glycosylation present in other granzymes. [provided by RefSeq, Jul 2008].
-
Gen-ID
- 3003
Target
-